Position in GLUE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,859,043
+$748,078 QoQ
Shares Held
76,820
+13.7% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 193 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. GLUE ranks #155 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in GLUE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,859,043 | 76,820 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,110,965 | 67,536 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $378,201 | 24,120 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $169,977 | 22,939 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $112,207 | 24,880 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $111,168 | 23,959 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $167,211 | 24,094 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $98,277 | 18,543 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $50,182 | 13,418 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $90,387 | 12,821 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $124,503 | 22,036 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $141,083 | 29,454 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $174,181 | 25,428 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $190,075 | 24,400 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $138,769 | 18,336 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $155,580 | 19,043 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $171,235 | 17,708 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $315,617 | 22,512 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $238,382 | 11,674 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $98,744 | 4,432 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||